HOSPITALIZATIONS FOR INFLAMMATORY BOWEL DISEASES IN THE BRAZILIAN POPULATION 2018–2023

Abstract

This article sought to evaluate the incidence of hospitalizations due to inflammatory bowel diseases (IBD) across all regions of Brazil, as well as the costs to the public health system, demographic profile, and mortality rates between 2018 and 2023. This was an ecological, descriptive, and cross-sectional study using data from the Hospital Morbidity System, obtained from the Department of Informatics of the Brazilian Unified Health System (DATASUS). The analyses included the number of hospitalizations, average length of stay, and hospitalization costs, in addition to information on sex, age group, race/skin color, and regional distribution. The results revealed a higher incidence of hospitalizations in the Southeast, Northeast, and South regions, predominantly among individuals aged 20 to 59 years. A growing trend in the number of cases was observed throughout the study period, with a total financial impact of R$ 26,264,131.37 on the public health system. Furthermore, complications related to IBD led to a significant increase in hospitalizations between 2018 and 2023. These findings highlight the relevance of IBD in the context of public health and reinforce the need for strategies focused on prevention, early diagnosis, and appropriate management in order to reduce complications, hospitalizations, and associated costs in Brazil.